Join the conversation as a panel of industry experts looks at the Affordable Care Act and the shift toward a consumer-driven, value-based health care system by examining the implications for life sciences companies.
How do life sciences companies respond to the growing demand for data-backed evidence of value and differentiation? With the ACA’s focus on preventative care, what can companies do to improve patient adherence and compliance? How does the industry move beyond new molecular entity innovation to find new, cost-effective solutions with significant outcome improvements? How will emerging technologies like mobile health and wearable devices disrupt the market?
Chicago Booth invites you to Boston for a discussion with Booth alumni and industry leaders who will share their expertise and perspective on the current environment. Hear their take on the future of the life sciences industry.